Avalo Therapeutics, Inc. (AVTX) vs Design Therapeutics, Inc. (DSGN)
Avalo Therapeutics, Inc. and Design Therapeutics, Inc. are both Biotechnology companies. Avalo Therapeutics, Inc. and Design Therapeutics, Inc. are of similar size ($843.1M and $809.3M). Across the 12 metrics below, Avalo Therapeutics, Inc. leads on 7 and Design Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AVTX | DSGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.72% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (36.27%) | (34.13%) | (57.72%) |
| Return on assets | (32.50%) | (32.33%) | (49.22%) |
| Return on invested capital | (118.21%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack